tradingkey.logo

LENSAR Inc

LNSR
11.440USD
-1.080-8.63%
Cierre 11/06, 16:00ETCotizaciones retrasadas 15 min
136.51MCap. mercado
PérdidaP/E TTM

Más Datos de LENSAR Inc Compañía

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.

Información de LENSAR Inc

Símbolo de cotizaciónLNSR
Nombre de la empresaLENSAR Inc
Fecha de salida a bolsaSep 21, 2020
Director ejecutivoMr. Nicholas T. (Nick) Curtis
Número de empleados140
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 21
Dirección2800 Discovery Drive
CiudadORLANDO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal32826
Teléfono18885367271
Sitio Webhttps://www.lensar.com/
Símbolo de cotizaciónLNSR
Fecha de salida a bolsaSep 21, 2020
Director ejecutivoMr. Nicholas T. (Nick) Curtis

Ejecutivos de LENSAR Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
543.27K
-1.34%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
239.04K
-2.99%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
85.57K
-7.93%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
80.84K
-8.36%
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
543.27K
-1.34%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
239.04K
-2.99%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
85.57K
-7.93%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
80.84K
-8.36%
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
7.75M
63.07%
Europe
2.41M
19.63%
Asia (excluding South Korea)
1.87M
15.21%
South Korea
181.00K
1.47%
Other
76.00K
0.62%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: vie., 15 de ago
Actualizado: vie., 15 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
North Run Capital, LP
9.21%
Curtis (Nicholas T)
6.63%
Brandes Investment Partners, L.P.
4.72%
Link (William J)
4.55%
BlackRock Institutional Trust Company, N.A.
4.48%
Otro
70.41%
Accionistas
Accionistas
Proporción
North Run Capital, LP
9.21%
Curtis (Nicholas T)
6.63%
Brandes Investment Partners, L.P.
4.72%
Link (William J)
4.55%
BlackRock Institutional Trust Company, N.A.
4.48%
Otro
70.41%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
23.51%
Individual Investor
19.70%
Hedge Fund
13.36%
Investment Advisor/Hedge Fund
7.08%
Bank and Trust
1.52%
Pension Fund
1.48%
Research Firm
0.66%
Otro
32.68%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
148
5.68M
47.60%
+154.65K
2025Q2
124
7.77M
65.87%
+342.80K
2025Q1
115
7.48M
63.69%
+236.19K
2024Q4
93
7.07M
60.29%
-575.26K
2024Q3
87
7.23M
62.19%
-377.24K
2024Q2
90
7.17M
61.87%
-380.16K
2024Q1
87
6.85M
59.77%
-601.54K
2023Q4
89
6.81M
60.46%
-688.43K
2023Q3
96
7.03M
62.74%
-797.20K
2023Q2
103
7.07M
63.18%
-1.15M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
North Run Capital, LP
1.10M
9.22%
--
--
Mar 23, 2025
Curtis (Nicholas T)
792.29K
6.64%
--
--
May 15, 2025
Brandes Investment Partners, L.P.
563.58K
4.72%
+18.89K
+3.47%
Jun 30, 2025
Link (William J)
550.64K
4.61%
+7.37K
+1.36%
May 23, 2025
BlackRock Institutional Trust Company, N.A.
534.89K
4.48%
+383.07K
+252.33%
Jun 30, 2025
The Vanguard Group, Inc.
506.16K
4.24%
+63.66K
+14.39%
Jun 30, 2025
Connaughton (Alan B.)
279.22K
2.34%
--
--
May 15, 2025
La Française AM
251.40K
2.11%
+125.40K
+99.52%
Jun 30, 2025
Lindstrom (Richard L)
246.41K
2.06%
+7.37K
+3.08%
May 23, 2025
Tudor Investment Corporation
236.71K
1.98%
-40.29K
-14.55%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
Ver más
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
iShares Micro-Cap ETF
Proporción0.02%
iShares Russell 2000 Growth ETF
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
Franklin US Small Cap Multifactor Index ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
ProShares Hedge Replication ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
Global X Russell 2000 ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI